Lucy Scientific Discovery is quietly Acquiring Premium Assets in the Hottest Industry

DENVER, Colo., September 12, 2023 (www.247marketnews.com)- Lucy Scientific Discovery (NASDAQ:LSDI) and Richard Nanula, Lucy’s CEO, followed last week’s High Times’ acquisition news with an additional acquisition, BlueSky Wellness Inc., a portfolio of plant-based wellness brands including Keoni, Keoni Sport, Blush Wellness and AMMA Healing.

BlueSky Wellness’ e-commerce brands generated over $20 million in each of its last two years and an adjusted Ebitda of $3 million, in 2022, and its product offerings enhance HighTimes’ products and platforms.

Lucy Scientific expects to have approximately 25 million shares issued and outstanding; and projects the two transactions on a consolidated basis to add a minimum of $30 million of revenue and $10 million of EBITDA for 2024, assuming both transactions close this year. Lucy expects to complete the BlueSky Wellness acquisition within 90 days and the High Times transaction in two weeks, subject to customary closing conditions.

Nanula, the deal’s architect, stated, “The addition of the BlueSky portfolio and its team allows us to capitalize on revenue opportunities. Coupled with our HighTimes acquisition, this strategically positions us for substantial near and long-term growth. This acquisition is a testament to our commitment to expand and grow our business, adding revenue that diversifies our company and should deliver significant value to our Lucy Scientific shareholders.”

Both transactions were all-stock upfront, with a 5-year payout, in stock or cash at Lucy’s discretion, based on EBITDA generated. The transactions are the latest deals Nanula structured and add to a career where he managed more than $50 billion worth of M&A and financing transactions. As EVP Finance & Strategy and CFO of Amgen (NASDAQ:AMGN), he conceived and executed 5 acquisitions, valued at $18 billion, including the biotech industry’s largest ever, at the time. As The Walt Disney Company’s (NYSE:DIS) EVP and CFO, Nanula led the more than $20 billion acquisition and financing of Capital Cities/ABC (ABC television network, ESPN). During his tenure, Disney’s revenues grew from $2 billion to over $20 billion and market capitalization from $3 billion to over $40 billion. As President and COO Starwood Hotels and Resorts, now part of Marriott (NASDAQ:MAR), Nanula integrated 3 acquired entities, Starwood Hotels, Westin and Sheraton ITT into a single $20 Billion enterprise, the largest hospitality company in the world, with over 1,000 hotels.

It’s not just the assets, it’s the timing, because Lucy Scientific Discovery is unveiling these acquisitions, just as the cannabis industry is heating up, following the Bloomberg report that the US Department of Health and Human Services sent a letter to the US DEA, in late August, recommending that cannabis be downgraded from a Schedule I to a Schedule III drug.

The reschedule recommendation, in late August, sparked a rally that seems to be gaining steam.

For example, after Aurora Cannabis (NASDAQ:ACB) announced, yesterday, that it repurchased approximately US$9 million of its convertible senior notes in multiple transactions and has approximately US$39 million of notes outstanding. The news caused Aurora Cannabis to rally to hit a high of $0.938 and close at $0.9108, up $0.3818 (+72.17%), on trading volume of 255,717,466 shares.

Canopy Growth’s (NASDAQ:CGC) gains were ever more pronounced and it a high of $1.79, yesterday, while it closed at $1.69, up $0.7582 (+81.37%), on trading volume of 278,725,685 shares. Yesterday’s closing price represents a move of over 400% higher than where it was in late August.

However, the industry is retreating this morning after Marijuana Moment reported that a Senate Banking Committee spokesperson that the anticipated Secure and Fair Enforcement (SAFE) Banking Act “markup won’t be next week,” but they still plan to move forward in the future.

Connect with 24/7 Market News:

www.247marketnews.com 

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.

DISCLOSURE: 24/7 Market News Inc. (247), owns and operates www.247marketnews.com is a third-party publisher and news release service provider which disseminates corporate news electronically through multiple online media platforms. 247 is NOT an affiliate with any of the companies mentioned in our reports. 247 is a news distribution service and is not registered with FINRA or any other professional licensing service. 247 is not an analyst, broker dealer or advisor, and holds no such licenses. 247 may NOT offer to buy, sell, or hold any security. 247 Venture Beats, and Breakfast bits and any other corporate profiles will NEVER be a solicitation or recommendation of any kind, of any security mentioned. The materials in all our releases are intended to be for informational purposes only and should never be considered research or due diligence on any company mentioned. All readers are encouraged to perform standard due diligence by reading the company’s filings at SEC.gov. Readers should consult their broker or licensed professional before investing in any company. All materials in this release are based on publicly available statements made by the companies. 247 is not liable for any investment decisions made by any readers or subscribers. Any investment could result in you losing all your money from investing in any stock. 247’s editor owns no shares of $LSDI and will not trade in the stock. Publisher has been paid to write and send relevant information concerning Lucy Scientific Discovery Inc. to interested readers. 24/7 has been paid up to twenty-five thousand dollars per week by Totaligent for continuous updates and coverage over the next three months 24/7 will use also be using Totaligent’s financial marketing tools and platform. Editors are paid to put a best-case scenario profile out to the investing public. This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 247 undertakes no obligation to update such statements.

For more information visit https://www.247marketnews.com/lsdi-lucy-scientific-discovery/

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.